Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy

• Gayathri Kandasamy,
• Elena N. Danilovtseva,
• Vadim V. Annenkov and
• Uma Maheswari Krishnan

Beilstein J. Nanotechnol. 2020, 11, 354–369, doi:10.3762/bjnano.11.26

• systems have emerged as a front-runner for gene delivery applications due to their polycationic nature, biocompatibility as well as the ability to escape the endosome by activating the proton sponge mechanism. In an earlier report, histidylated poly(ʟ-lysine) was found to exhibit high transfection

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• endosomal escape to reach the cytosol. Multiple strategies for overcoming the endosomal entrapment have been designed [52]. One of the most widely employed is the incorporation of polycationic groups on the particle surface such as poly(ethyleneimine), cationic dendrimers or poly(histidine) chains [53

A biofunctionalizable ink platform composed of catechol-modified chitosan and reduced graphene oxide/platinum nanocomposite

• Peter Sobolewski,
• Agata Goszczyńska,
• Małgorzata Aleksandrzak,
• Karolina Urbaś,
• Joanna Derkowska,
• Agnieszka Bartoszewska,
• Jacek Podolski,
• Ewa Mijowska and
• Mirosława El Fray

Beilstein J. Nanotechnol. 2017, 8, 1508–1514, doi:10.3762/bjnano.8.151

• . First, we prepare dispersions of reduced graphene oxide (rGO) decorated with platinum nanoparticles (rGO–Pt) in ethylene glycol (EG). As the polymer matrix, we utilize chitosan (CHI), a polycationic biopolymer that provides excellent film-forming properties and easy-to-functionalize amine groups [8

Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

• Gamze Varan,
• Juan M. Benito,
• Carmen Ortiz Mellet and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1457–1468, doi:10.3762/bjnano.8.145

• during chemotherapy. Amphiphilic cyclodextrins are favored oligosaccharides as drug delivery systems for anticancer drugs, having the ability to spontaneously form nanoparticles without surfactant or co-solvents. In the past few years, polycationic, amphiphilic cyclodextrins were introduced as effective

• agents for gene delivery in the form of nanoplexes. In this study, the potential of polycationic, amphiphilic cyclodextrin nanoparticles were evaluated in comparison to non-ionic amphiphilic cyclodextrins and core–shell type cyclodextrin nanoparticles for paclitaxel delivery to breast tumors. Pre

• -formulation studies were used as a basis for selecting the suitable organic solvent and surfactant concentration for the novel polycationic cyclodextrin nanoparticles. The nanoparticles were then extensively characterized with particle size distribution, polydispersity index, zeta potential, drug loading

Characterisation of thin films of graphene–surfactant composites produced through a novel semi-automated method

• Nik J. Walch,
• Alexei Nabok,
• Frank Davis and
• Séamus P. J. Higson

Beilstein J. Nanotechnol. 2016, 7, 209–219, doi:10.3762/bjnano.7.19

• alternated with layers of polycationic species such as polyallylamine hydrochloride (PAH) or polyethyleneimine (PEI). Alternating layers of graphene(−)SDS and graphene(+)CTAB was also attempted. The films were deposited by consecutive dipping of gold-coated glass or silicon wafers into 1 mg·mL−1 solutions of

Fabrication and characterization of novel multilayered structures by stereocomplexion of poly(D-lactic acid)/poly(L-lactic acid) and self-assembly of polyelectrolytes

• Elena Dellacasa,
• Li Zhao,
• Gesheng Yang,
• Laura Pastorino and
• Gleb B. Sukhorukov

Beilstein J. Nanotechnol. 2016, 7, 81–90, doi:10.3762/bjnano.7.10

• for sustained release. Keywords: biocompatibility; layer-by-layer assembly; microcapsules; poly(lactic acids); stereocomplex; Introduction The polycationic/polyanionic layer-by-layer (LBL) deposition on surfaces has been widely studied since the first description by Decher et al. [1][2][3]. The

pH-Triggered release from surface-modified poly(lactic-co-glycolic acid) nanoparticles

• Manuel Häuser,
• Klaus Langer and
• Monika Schönhoff

Beilstein J. Nanotechnol. 2015, 6, 2504–2512, doi:10.3762/bjnano.6.260

• modified by successive adsorption of four polyelectrolyte layers in total, containing in particular the weak polyanion PAA. We demonstrate that an appropriate pH stimulus induces a controlled release of the polycationic species poly(diallyldimethylammonium chloride) (PDADMAC). The successful pH-triggered

Chemoselective silicification of synthetic peptides and polyamines

• Maryna Abacilar,
• Fabian Daus and
• Armin Geyer

Beilstein J. Nanotechnol. 2015, 6, 103–110, doi:10.3762/bjnano.6.10

• oligopropylenamines [6], polycationic peptides [7], proteins [8], and polysaccharides [9]. Even higher contents of organic material are found in sponges in which the biosilica is associated with collagen-type proteins [10]. The common feature of all these organic molecules is their modular assembly. We and others